Eye Sight Medical Center Tonawanda, NY - 14150

Eye Sight Medical Center is categorized under Family Practice Doctors in Tonawanda, NY and active since 1974.

Eye Sight Medical Center was established in 1974, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Judy Hollander, Office Manager at the company’s single location by writing to 1890 Colvin Boulevard, Tonawanda, New York NY 14150 or by phoning (716) 837-5200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Eye Sight Medical Center
Contact Person: Judy Hollander, Office Manager
Address: 1890 Colvin Boulevard, Tonawanda, New York 14150
Phone Number: (716) 837-5200
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 1974
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Family Practice Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Eye Sight Medical Center was started in 1974 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Judy Hollander, Office Manager for inquiries that concern Eye Sight Medical Center by calling the company number (716) 837-5200, as your correspondence is most welcome. Additionally, the physical location of the single location of Eye Sight Medical Center can be found at the coordinates 42.98908,-78.85282 as well as the street address 1890 Colvin Boulevard in Tonawanda, New York 14150.

For its online presence, you may visit Eye Sight Medical Center’s website at and engage with its social media outlets through on Twitter and on Facebook.